BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36857183)

  • 21. The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.
    Liao L; Testa JR; Yang H
    Cancer Genet; 2015 May; 208(5):206-14. PubMed ID: 25873528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function.
    Alcázar I; Cortés I; Zaballos A; Hernandez C; Fruman DA; Barber DF; Carrera AC
    Blood; 2009 Apr; 113(14):3198-208. PubMed ID: 19190244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p85β phosphoinositide 3-kinase subunit regulates tumor progression.
    Cortés I; Sánchez-Ruíz J; Zuluaga S; Calvanese V; Marqués M; Hernández C; Rivera T; Kremer L; González-García A; Carrera AC
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11318-23. PubMed ID: 22733740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation.
    Yang W; Zhang Z; Li L; Zhang K; Xu Y; Xia M; Zhou J; Gong Y; Chen J; Gong K
    Cell Death Dis; 2023 Mar; 14(3):212. PubMed ID: 36966163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdc37 facilitates cell survival of colorectal carcinoma via activating the CDK4 signaling pathway.
    Zhu J; Yan F; Tao J; Zhu X; Liu J; Deng S; Zhang X
    Cancer Sci; 2018 Mar; 109(3):656-665. PubMed ID: 29288563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.
    Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
    Eur J Pharmacol; 2022 May; 922():174804. PubMed ID: 35257717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs.
    Liu W; Yan B; Yu H; Ren J; Peng M; Zhu L; Wang Y; Jin X; Yi L
    Int J Biol Sci; 2022; 18(4):1401-1414. PubMed ID: 35280681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas.
    Yuan Y; Li X; Xu Y; Zhao H; Su Z; Lai D; Yang W; Chen S; He Y; Li X; Liu L; Xu G
    Cancer Sci; 2019 Nov; 110(11):3533-3542. PubMed ID: 31489722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms.
    Kim JY; Jayne LA; Bai Y; Feng MJHH; Clark MA; Chung S; W Christman J; Cianciolo RE; Pabla NS
    Biochem Pharmacol; 2020 Jul; 177():113939. PubMed ID: 32229099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
    Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
    J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mobility group box 1 protein is methylated and transported to cytoplasm in clear cell renal cell carcinoma.
    Wu F; Zhao ZH; Ding ST; Wu HH; Lu JJ
    Asian Pac J Cancer Prev; 2013; 14(10):5789-95. PubMed ID: 24289579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.
    Tao T; Yang X; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H; Jiang WG; He J
    Oncogene; 2017 Nov; 36(44):6119-6131. PubMed ID: 28692056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
    Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
    Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.